Moderna is now overvalued after cancer vaccine-led stock surge, Rothschild & Co. says
- Posted on September 3, 2026
- By CNBC
- 0 Views
- 1 min read
In brief
Generating AI summary…
Moderna is now overvalued after cancer vaccine-led stock surge, Rothschild & Co. says
The research firm downgraded the biotechnology stock to sell from neutral.